Analysed NRX PHARMACEUTICALS INC (NRXP:NASDAQ) News Sources
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality
07-05-2026
yahoo.com
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update
14-05-2026
yahoo.com
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update
18-05-2026
yahoo.com
Here is why NRx Pharmaceuticals, Inc. (NRXP) is among the Best Rated Penny Stocks to Buy According to Wall Street Analysts
24-05-2026
yahoo.com
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
27-05-2026
yahoo.com
NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026
28-05-2026
yahoo.com
What is the current price of NRX PHARMACEUTICALS INC (NRXP:NASDAQ)?
The current price of NRX PHARMACEUTICALS INC (NRXP:NASDAQ) is $4.05.
NRX PHARMACEUTICALS INC (NRXP:NASDAQ) absolute price change since previous trading day?
The absolute price change of NRX PHARMACEUTICALS INC (NRXP:NASDAQ) since the previous trading day is $-0.57.
NRX PHARMACEUTICALS INC (NRXP:NASDAQ) percentage price change since previous trading day?
The percentage price change of NRX PHARMACEUTICALS INC (NRXP:NASDAQ) since the previous trading day is -12.3377%.
What is the most recent average sentiment score for NRX PHARMACEUTICALS INC (NRXP:NASDAQ)?
The most recent average sentiment score for NRX PHARMACEUTICALS INC (NRXP:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for NRX PHARMACEUTICALS INC (NRXP:NASDAQ)?
The most recent sentiment for NRX PHARMACEUTICALS INC (NRXP:NASDAQ) is .
SEC-8K** Filing Available For NRX PHARMACEUTICALS INC (NRXP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.